Back to search

Article

Healthy B cells: allies or adversaries of CAR-T cell immunotherapy?

2024-11-11

Abstract excerpt

Chimeric antigen receptor (CAR)-T cell immunotherapy has achieved significant success against various haematological cancers, including B-cell malignancies. Its efficacy against B-cell cancers is influenced by the presence of healthy B-cells expressing the target antigen, and B-cell aplasia (BCA) serves as an indicator of successful therapy outcome. However, the precise influence of healthy B-cells on the in vivo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
571b6ec9-ab40-5287-b6ef-a467fe226140
DOI
10.1101/2024.11.08.622644
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Healthy B cells: allies or adversaries of CAR-T cell immunotherapy?DOI 10.1101/2024.11.08.622644
Select a neighboring publication to make it the new centre.